Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 May 1;331(Pt 3):809–813. doi: 10.1042/bj3310809

A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation.

Y C Kudva 1, C Mueske 1, P C Butler 1, N L Eberhardt 1
PMCID: PMC1219421  PMID: 9560308

Abstract

Human islet amyloid polypeptide (IAPP) is a 37-residue peptide that is co-secreted with insulin by the beta-cell and might be involved in the pathogenesis of non-insulin-dependent diabetes mellitus. We developed an improved assay in vitro based on the fluorescence of bound thioflavin T to study factors affecting amyloidogenesis. Monomeric IAPP formed amyloid fibrils, as detected by increased fluorescence and by electron microscopy. Fluorimetric analysis revealed that the initial rate of amyloid formation was: (1) proportional to the peptide monomer concentration, (2) maximal at pH 9.5, (3) maximal at 200 mMKCl, and (4) proportional to temperature from 4 to 37 degreesC. We found that 5-fold and 10-fold molar excesses of proinsulin inhibited fibril formation by 39% and 59% respectively. Insulin was somewhat more potent with 5-fold and 10-fold molar excesses inhibiting fibril formation by 69% and 73% respectively, whereas C-peptide had no effect at these concentrations. Thus at physiological ratios of IAPP to insulin, insulin and proinsulin, but not C-peptide, can retard amyloidogenesis. Because insulin resistance or hyperglycaemia increase the IAPP-to-insulin ratio, increased intracellular IAPP compared with insulin expression in genetically predisposed individuals might contribute to intracellular amyloid formation, beta-cell death and the genesis of non-insulin-dependent diabetes mellitus.

Full Text

The Full Text of this article is available as a PDF (440.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELL E. T. Hyalinization of the islet of Langerhans in diabetes mellitus. Diabetes. 1952 Sep-Oct;1(5):341–344. doi: 10.2337/diab.1.5.341. [DOI] [PubMed] [Google Scholar]
  2. Barasch J., Kiss B., Prince A., Saiman L., Gruenert D., al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature. 1991 Jul 4;352(6330):70–73. doi: 10.1038/352070a0. [DOI] [PubMed] [Google Scholar]
  3. Betsholtz C., Christmansson L., Engström U., Rorsman F., Svensson V., Johnson K. H., Westermark P. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 1989 Jul 17;251(1-2):261–264. doi: 10.1016/0014-5793(89)81467-x. [DOI] [PubMed] [Google Scholar]
  4. Chargé S. B., de Koning E. J., Clark A. Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro. Biochemistry. 1995 Nov 7;34(44):14588–14593. doi: 10.1021/bi00044a038. [DOI] [PubMed] [Google Scholar]
  5. Clark A., Cooper G. J., Lewis C. E., Morris J. F., Willis A. C., Reid K. B., Turner R. C. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet. 1987 Aug 1;2(8553):231–234. doi: 10.1016/s0140-6736(87)90825-7. [DOI] [PubMed] [Google Scholar]
  6. Couce M., O'Brien T. D., Moran A., Roche P. C., Butler P. C. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab. 1996 Mar;81(3):1267–1272. doi: 10.1210/jcem.81.3.8772610. [DOI] [PubMed] [Google Scholar]
  7. DeFronzo R. A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988 Jun;37(6):667–687. doi: 10.2337/diab.37.6.667. [DOI] [PubMed] [Google Scholar]
  8. Hutton J. C. The internal pH and membrane potential of the insulin-secretory granule. Biochem J. 1982 Apr 15;204(1):171–178. doi: 10.1042/bj2040171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Janciauskiene S., Eriksson S., Carlemalm E., Ahrén B. B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun. 1997 Jul 30;236(3):580–585. doi: 10.1006/bbrc.1997.7014. [DOI] [PubMed] [Google Scholar]
  10. Kudva Y. C., Hiddinga H. J., Butler P. C., Mueske C. S., Eberhardt N. L. Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett. 1997 Oct 13;416(1):117–121. doi: 10.1016/s0014-5793(97)01180-0. [DOI] [PubMed] [Google Scholar]
  11. LeVine H., 3rd Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993 Mar;2(3):404–410. doi: 10.1002/pro.5560020312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lorenzo A., Razzaboni B., Weir G. C., Yankner B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994 Apr 21;368(6473):756–760. doi: 10.1038/368756a0. [DOI] [PubMed] [Google Scholar]
  13. Ludvik B., Clodi M., Kautzky-Willer A., Capek M., Hartter E., Pacini G., Prager R. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia. 1993 Jan;36(1):84–87. doi: 10.1007/BF00399099. [DOI] [PubMed] [Google Scholar]
  14. Lukacs G. L., Chang X. B., Kartner N., Rotstein O. D., Riordan J. R., Grinstein S. The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH. J Biol Chem. 1992 Jul 25;267(21):14568–14572. [PubMed] [Google Scholar]
  15. Naiki H., Higuchi K., Hosokawa M., Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem. 1989 Mar;177(2):244–249. doi: 10.1016/0003-2697(89)90046-8. [DOI] [PubMed] [Google Scholar]
  16. Naiki H., Higuchi K., Matsushima K., Shimada A., Chen W. H., Hosokawa M., Takeda T. Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T. Lab Invest. 1990 Jun;62(6):768–773. [PubMed] [Google Scholar]
  17. Naiki H., Higuchi K., Nakakuki K., Takeda T. Kinetic analysis of amyloid fibril polymerization in vitro. Lab Invest. 1991 Jul;65(1):104–110. [PubMed] [Google Scholar]
  18. O'Brien T. D., Butler P. C., Kreutter D. K., Kane L. A., Eberhardt N. L. Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis. Am J Pathol. 1995 Sep;147(3):609–616. [PMC free article] [PubMed] [Google Scholar]
  19. Pieber T. R., Stein D. T., Ogawa A., Alam T., Ohneda M., McCorkle K., Chen L., McGarry J. D., Unger R. H. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. Am J Physiol. 1993 Sep;265(3 Pt 1):E446–E453. doi: 10.1152/ajpendo.1993.265.3.E446. [DOI] [PubMed] [Google Scholar]
  20. Porte D., Jr, Kahn S. E. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction? Diabetes. 1989 Nov;38(11):1333–1336. doi: 10.2337/diab.38.11.1333. [DOI] [PubMed] [Google Scholar]
  21. Poyner D. R., Andrew D. P., Brown D., Bose C., Hanley M. R. Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. Br J Pharmacol. 1992 Feb;105(2):441–447. doi: 10.1111/j.1476-5381.1992.tb14272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rhodes C. J., Alarcón C. What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes. 1994 Apr;43(4):511–517. doi: 10.2337/diab.43.4.511. [DOI] [PubMed] [Google Scholar]
  23. Sanke T., Hanabusa T., Nakano Y., Oki C., Okai K., Nishimura S., Kondo M., Nanjo K. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991 Feb;34(2):129–132. doi: 10.1007/BF00500385. [DOI] [PubMed] [Google Scholar]
  24. Van Dyke R. W., Root K. V., Schreiber J. H., Wilson J. M. Role of CFTR in lysosome acidification. Biochem Biophys Res Commun. 1992 Apr 15;184(1):300–305. doi: 10.1016/0006-291x(92)91192-s. [DOI] [PubMed] [Google Scholar]
  25. Westermark P., Li Z. C., Westermark G. T., Leckström A., Steiner D. F. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett. 1996 Feb 5;379(3):203–206. doi: 10.1016/0014-5793(95)01512-4. [DOI] [PubMed] [Google Scholar]
  26. Westermark P., Wernstedt C., Wilander E., Hayden D. W., O'Brien T. D., Johnson K. H. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3881–3885. doi: 10.1073/pnas.84.11.3881. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES